Sincerity Applied Materials Holdings Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Sincerity Applied Materials Holdings Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $63.0K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $482.6K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $677.5K | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | $1.56M | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | $2.15M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $914.6K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $353.1K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $276.3K | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | $79.4K | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | $0 | Oct 17, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $41.6K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $122.5K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $102.6K | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | $85.6K | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | $200.0K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $275.1K | Apr 17, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | ($61.3K) | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $85.6K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($11.7K) | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | $761.8K | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | ($3.99M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $65.5K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($2.20M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | ($2.79M) | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | ($1.23M) | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | ($37.2K) | Oct 17, 2013 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | ($87.2K) | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $74.2K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($32.4K) | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | ($361.5K) | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | ($2.59M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $129.7K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($2.15M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | ($3.04M) | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | ($1.22M) | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | ($71.2K) | Oct 17, 2013 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $32.9K | Mar 31, 2017 |
| FY2016 | Dec 31, 2015 | $59.9K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $320.0K | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | $78.8K | Mar 25, 2015 |
| FY2013 | Dec 31, 2012 | $165.4K | May 21, 2014 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $35.7K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $236.7K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $96.2K | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | ($636.4K) | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | ($61.9K) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($12.9K) | Apr 17, 2018 |
| FY2012 | Aug 31, 2012 | ($46.6K) | Dec 14, 2012 |
| FY2012 | Aug 31, 2011 | ($8.6K) | Dec 14, 2012 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $0 | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | $0 | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | $5.2K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $304 | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $9.9K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $6.9K | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | $0 | Mar 25, 2015 |
| FY2013 | Dec 31, 2012 | $2.8K | May 21, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $713.1K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $785.1K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $646.9K | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | $565.8K | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | $294.2K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $128.5K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $1.46M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.38M | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | $959.7K | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | $0 | Oct 17, 2013 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $662.2K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $688.9K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $600.8K | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | $560.2K | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | $2.38M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $373.9K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $1.13M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.03M | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | $989.7K | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | $48.2K | Oct 17, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $50.9K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $96.3K | Mar 30, 2022 |
| FY2021 | Dec 31, 2019 | $46.1K | Mar 30, 2022 |
| FY2020 | Dec 31, 2018 | $5.7K | Sep 14, 2021 |
| FY2019 | Dec 31, 2017 | ($2.09M) | Aug 25, 2021 |
| FY2018 | Dec 31, 2016 | ($245.5K) | Apr 15, 2019 |
| FY2017 | Dec 31, 2015 | ($298.1K) | Apr 17, 2018 |
| FY2015 | Dec 31, 2014 | $427.7K | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | $29.5K | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | ($48.2K) | Oct 17, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | ($3.49M) | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | ($3.43M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($3.51M) | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | ($3.50M) | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | ($4.26M) | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | ($272.3K) | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($6.99M) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | ($4.79M) | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | ($2.00M) | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | $147.1K | Oct 17, 2013 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $1.1K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $4.2K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $22.8K | Sep 14, 2021 |
| FY2020 | Dec 31, 2018 | $23.2K | Sep 14, 2021 |
| FY2019 | Dec 31, 2017 | $63.6K | Aug 25, 2021 |
| FY2018 | Dec 31, 2016 | $33.0K | Apr 15, 2019 |
| FY2017 | Dec 31, 2015 | $12.3K | Apr 17, 2018 |
| FY2016 | Dec 31, 2014 | $233.1K | Mar 31, 2017 |
| FY2015 | Dec 31, 2013 | $891.6K | Mar 25, 2016 |
| FY2013 | Aug 31, 2013 | $0 | Oct 17, 2013 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $68.8K | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | $107.8K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $129.9K | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | $131.3K | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | $72.3K | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | $82.6K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $636.9K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $91.9K | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | $238.0K | Mar 25, 2015 |
| FY2013 | Dec 31, 2012 | $267.5K | May 21, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 73.59M | Mar 30, 2022 |
| FY2021 | Dec 31, 2020 | 49.48M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | 49.48M | Sep 14, 2021 |
| FY2019 | Dec 31, 2018 | 49.48M | Aug 25, 2021 |
| FY2018 | Dec 31, 2017 | 49.48M | Apr 15, 2019 |
| FY2017 | Dec 31, 2016 | 45.21M | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | 36.91M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | 33.18M | Mar 25, 2016 |
| FY2014 | Dec 31, 2013 | 34.27M | Mar 25, 2015 |
| FY2013 | Aug 31, 2013 | 197.50M | Oct 17, 2013 |